Cue Biopharma, Inc.
Hedge Funds Holdings
Last updated:
Cue Biopharma, Inc.‘s stocks are currently a part of 38 hedge funds’ portfolios, which represents 16.74% of the total amount of its stocks outstanding. This makes up a total of 5.96M shares of Cue Biopharma, Inc.. Compared to the previous quarter, the number fell by -53.23% or -6.79M shares fewer. As for the holding position changes, 23.68% (9) of current hedge fund investors increased the number of shares held, 31.58% (12) of current holders sold a part of the shares held, and 15.79% (6) closed the holdings completely. 6 hedge funds are new holders of Cue Biopharma, Inc. stock in Q1 2023, it is 15.79% of total holders.
Hedge funds holding Cue Biopharma (Q2 2018 – Q1 2023)
| Q2 2018 | 39 |
|---|---|
| Q3 2018 | 36 |
| Q4 2018 | 35 |
| Q1 2019 | 37 |
| Q2 2019 | 36 |
| Q3 2019 | 44 |
| Q4 2019 | 62 |
| Q1 2020 | 74 |
| Q2 2020 | 99 |
| Q3 2020 | 92 |
| Q4 2020 | 97 |
| Q1 2021 | 89 |
| Q2 2021 | 90 |
| Q3 2021 | 89 |
| Q4 2021 | 90 |
| Q1 2022 | 96 |
| Q2 2022 | 71 |
| Q3 2022 | 61 |
| Q4 2022 | 59 |
| Q1 2023 | 38 |
Hedge funds changes in Cue Biopharma positions (Q2 2018 – Q1 2023)
| Q2 2018 | 11 | 19 | 5 | 1 | 3 |
|---|---|---|---|---|---|
| Q3 2018 | 3 | 16 | 7 | 6 | 4 |
| Q4 2018 | 2 | 14 | 12 | 3 | 4 |
| Q1 2019 | 4 | 10 | 16 | 2 | 5 |
| Q2 2019 | 4 | 19 | 5 | 3 | 5 |
| Q3 2019 | 10 | 21 | 6 | 2 | 5 |
| Q4 2019 | 25 | 22 | 8 | 7 | 0 |
| Q1 2020 | 19 | 22 | 16 | 6 | 11 |
| Q2 2020 | 32 | 39 | 18 | 7 | 3 |
| Q3 2020 | 11 | 40 | 23 | 17 | 1 |
| Q4 2020 | 13 | 40 | 22 | 7 | 15 |
| Q1 2021 | 6 | 31 | 33 | 14 | 5 |
| Q2 2021 | 11 | 29 | 32 | 10 | 8 |
| Q3 2021 | 5 | 30 | 30 | 6 | 18 |
| Q4 2021 | 14 | 35 | 26 | 13 | 2 |
| Q1 2022 | 21 | 28 | 27 | 13 | 7 |
| Q2 2022 | 13 | 29 | 21 | 35 | -27 |
| Q3 2022 | 4 | 12 | 30 | 14 | 1 |
| Q4 2022 | 12 | 13 | 18 | 14 | 2 |
| Q1 2023 | 6 | 9 | 12 | 6 | 5 |
Hedge funds changes in Cue Biopharma stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 443,000 |
| Q2 2020 | 1,292,000 | 1,527,000 |
| Q3 2020 | 636,000 | 453,000 |
| Q4 2020 | 359,000 | 2,723,000 |
| Q1 2021 | 732,000 | 3,061,000 |
| Q2 2021 | 814,000 | 1,679,000 |
| Q3 2021 | 1,725,000 | 745,000 |
| Q4 2021 | 1,640,000 | 1,107,000 |
| Q1 2022 | 1,112,000 | 752,000 |
| Q2 2022 | 160,000 | 173,000 |
| Q3 2022 | 87,000 | 42,000 |
| Q4 2022 | 201,110 | 75,470 |
| Q1 2023 | 30,062,000 | 42,535,000 |